DER1 Antibody

What is DER1/Derlin-1 and what is its biological significance?

DER1/Derlin-1 is a functional component of endoplasmic reticulum-associated degradation (ERAD) for misfolded luminal proteins. It forms homotetramers which encircle a large channel traversing the endoplasmic reticulum (ER) membrane. This structure allows for the retrotranslocation of misfolded proteins from the ER into the cytosol where they are ubiquitinated and degraded by the proteasome .

DER1/Derlin-1 contains four transmembrane domains with its N and C termini protruding into the cytoplasm, which contribute to its function . These structural features are critical for its role in protein quality control within the ER. The protein also participates in ER stress-induced pre-emptive quality control mechanisms, selectively attenuating the translocation of newly synthesized proteins into the ER and rerouting them to the cytosol for proteasomal degradation .

What experimental applications are DER1/Derlin-1 antibodies suitable for?

DER1/Derlin-1 antibodies have been validated for multiple experimental applications, including:

• Western blotting (WB): Effective for detecting the 29 kDa DER1/Derlin-1 protein

• Immunoprecipitation (IP): Useful for studying protein-protein interactions

• Immunohistochemistry on paraffin-embedded sections (IHC-P)

These antibodies have demonstrated reactivity with both human and mouse samples, making them versatile tools for comparative studies across species . When selecting an antibody, researchers should consider the specific epitope recognition and validate cross-reactivity with their experimental model system.

How is DER1/Derlin-1 involved in pathogen interactions and immune evasion?

During cytomegalovirus infection, DER1/Derlin-1 plays a central role in the export and subsequent degradation of MHC class I heavy chains through its interaction with the viral US11 protein. This mechanism allows the virus to associate with MHC class I molecules, facilitating their degradation and thereby evading immune detection .

Additionally, DER1/Derlin-1 participates in the degradation process of misfolded cytomegalovirus US2 protein, further demonstrating its involvement in host-pathogen interactions . This function highlights the protein's importance not only in normal cellular protein quality control but also as a target that pathogens exploit for immune evasion strategies.

What are the optimal Western blotting conditions for detecting DER1/Derlin-1?

For successful Western blot detection of DER1/Derlin-1, the following parameters have been experimentally validated:

Researchers should include appropriate positive controls such as HeLa or 293T cell lysates, which express detectable levels of endogenous DER1/Derlin-1 .

What strategies can be employed to validate DER1/Derlin-1 antibody specificity?

To ensure experimental rigor, DER1/Derlin-1 antibody specificity should be validated through multiple approaches:

• Positive and negative controls:

  • Use lysates from cells with confirmed DER1/Derlin-1 expression as positive controls

  • Employ CRISPR/Cas9 knockout or siRNA knockdown samples as negative controls

• Peptide competition assays:

  • Pre-incubate the antibody with the immunizing peptide prior to application

  • Loss of signal confirms epitope-specific binding

• Cross-reactivity assessment:

  • Test against related proteins such as other Derlin family members

  • Evaluate species cross-reactivity based on sequence homology

• Multiple detection methods:

  • Confirm findings using complementary techniques (WB, IP, IHC)

  • Use antibodies recognizing different epitopes of DER1/Derlin-1

• Molecular weight verification:

  • Confirm that the detected protein corresponds to the predicted 29 kDa size

What are the critical parameters for successful immunoprecipitation of DER1/Derlin-1?

Immunoprecipitation experiments with DER1/Derlin-1 antibodies require careful optimization of several parameters:

• Antibody amount: Effective IP has been achieved using 3 μg of antibody per mg of lysate

• Lysate preparation: Total lysate amounts of approximately 1 mg provide sufficient material for detection

• Loading for analysis: Typically, 20% of immunoprecipitated material yields detectable signals

• Lysis buffer composition: Should contain appropriate detergents (e.g., NP-40, Triton X-100) for membrane protein solubilization while preserving relevant protein-protein interactions

• Controls: Include isotype-matched control antibodies to identify non-specific binding

• Preclearing: Consider preclearing lysates to reduce background

These parameters may require adjustment based on the specific experimental system and the abundance of DER1/Derlin-1 in the samples being analyzed.

How can researchers investigate the structural determinants of DER1/Derlin-1 function?

Investigating structure-function relationships for DER1/Derlin-1 requires sophisticated experimental approaches:

• Mutagenesis studies:

  • Target conserved residues within transmembrane domains

  • Modify the N- and C-terminal regions that protrude into the cytoplasm and contribute to function

  • Assess functional consequences through ERAD substrate degradation assays

• Cross-species complementation:

  • Utilize the finding that C. elegans ortholog R151.6 can complement der1-defective phenotypes in yeast

  • Create chimeric proteins to identify critical functional domains

• Channel property analysis:

  • Investigate the biophysical properties of the channel formed by DER1/Derlin-1 homotetramers

  • Characterize the lateral gate within the membrane that provides direct access for membrane proteins

• Interaction mapping:

  • Identify residues critical for interactions with partners such as VCP/p97

  • Determine binding interfaces with ERAD substrates and other ERAD machinery components

• High-resolution structural studies:

  • Apply cryo-electron microscopy to visualize channel architecture

  • Use cross-linking mass spectrometry to capture dynamic interactions

What experimental approaches can elucidate DER1/Derlin-1's role in regulating growth factor signaling?

DER1/Derlin-1 indirectly regulates the insulin-like growth factor receptor signaling pathway by controlling the steady-state expression of the IGF1R receptor . To investigate this regulatory function:

• Receptor turnover studies:

  • Conduct pulse-chase experiments to measure IGF1R half-life with and without DER1/Derlin-1 modulation

  • Use cycloheximide chase assays to monitor receptor degradation kinetics

• Signaling pathway analysis:

  • Assess phosphorylation status of downstream effectors (Akt, ERK)

  • Measure receptor-mediated gene expression changes

• Domain mapping:

  • Identify regions of DER1/Derlin-1 necessary for IGF1R regulation

  • Determine if direct or indirect mechanisms are involved

• Cell-type specificity assessment:

  • Compare effects across different cell types with varying baseline IGF1R expression

  • Correlate with cell-specific metabolic or growth phenotypes

• In vivo modeling:

  • Generate tissue-specific DER1/Derlin-1 knockout models

  • Evaluate physiological consequences of altered growth factor signaling

How can researchers distinguish between different DER1 homologs in experimental systems?

Different species possess DER1 homologs with varying functions. For example, yeast has Der1p and a homolog Dfm1p that does not appear to be involved in ERAD . To distinguish between these homologs:

This comparative approach can reveal evolutionary conservation and divergence in DER1 function across different organisms, providing insights into fundamental ERAD mechanisms.

What are common challenges in detecting DER1/Derlin-1 and how can they be addressed?

When working with DER1/Derlin-1 antibodies, researchers may encounter several technical challenges:

• Low signal intensity:

  • Increase antibody concentration (start with manufacturer recommendations, e.g., 0.04 μg/mL)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Enrich target protein by immunoprecipitation before detection

  • Use more sensitive detection systems (enhanced chemiluminescence)

• High background:

  • Optimize blocking conditions (test BSA vs. milk proteins)

  • Increase washing duration and detergent concentration

  • Reduce secondary antibody concentration

  • Pre-absorb antibodies with cell/tissue lysates lacking target protein

• Non-specific bands:

  • Verify predicted molecular weight (29 kDa for DER1/Derlin-1)

  • Include appropriate positive controls (HeLa, 293T lysates)

  • Test antibody specificity through knockout/knockdown controls

  • Consider post-translational modifications that might alter migration

• Membrane protein solubilization issues:

  • Optimize detergent type and concentration in lysis buffers

  • Avoid excessive heating of samples containing membrane proteins

  • Consider specialized membrane protein extraction protocols

How can researchers study DER1/Derlin-1 interactions with ERAD machinery components?

Investigating DER1/Derlin-1's interactions with other ERAD components requires specialized approaches:

• Co-immunoprecipitation strategies:

  • Use DER1/Derlin-1 antibodies at validated concentrations (3 μg/mg lysate)

  • Employ crosslinking to capture transient interactions

  • Consider native vs. denaturing conditions based on interaction stability

• Proximity labeling approaches:

  • Express DER1/Derlin-1 fused to BioID or APEX2

  • Identify nearby proteins through biotinylation and mass spectrometry

  • Validate interactions through orthogonal methods

• Fluorescence-based interaction studies:

  • Utilize FRET, BiFC, or split-luciferase assays

  • Visualize interactions in living cells

  • Assess dynamics during ERAD substrate processing

• Reconstitution systems:

  • Purify DER1/Derlin-1 and interaction partners

  • Reconstitute minimal functional complexes in vitro

  • Measure biochemical activities in defined systems

• Structural biology approaches:

  • Analyze co-crystal structures when available

  • Use electron microscopy to visualize multiprotein complexes

What considerations are important when studying DER1/Derlin-1 in disease models?

When investigating DER1/Derlin-1's role in disease contexts:

• Expression analysis in disease tissues:

  • Use validated antibodies with appropriate controls

  • Compare expression levels across normal vs. pathological samples

  • Consider cell-type specific changes within heterogeneous tissues

• Genetic variants assessment:

  • Evaluate the functional impact of disease-associated variants

  • Create cellular models expressing these variants

  • Measure effects on ERAD efficiency and substrate degradation

• Stress response dynamics:

  • Monitor DER1/Derlin-1 expression and localization during disease-relevant stress conditions

  • Correlate with markers of ER stress (BiP, CHOP, XBP1 splicing)

• Therapeutic targeting considerations:

  • Assess the effects of modulating DER1/Derlin-1 levels or function

  • Evaluate potential off-target effects on essential cellular processes

  • Consider consequences for protein homeostasis in different cell types

• Model system selection:

  • Choose models that recapitulate relevant disease aspects

  • Consider species-specific differences in DER1/Derlin-1 function

How might single-cell approaches advance our understanding of DER1/Derlin-1 function?

Single-cell technologies offer new opportunities to study DER1/Derlin-1 with unprecedented resolution:

• Single-cell transcriptomics:

  • Correlate DER1/Derlin-1 expression with other ERAD components at single-cell level

  • Identify cell populations with distinct expression patterns

  • Map changes during differentiation or disease progression

• Spatial transcriptomics/proteomics:

  • Visualize DER1/Derlin-1 expression in tissue contexts

  • Identify spatial relationships with other ERAD machinery

• Live-cell imaging at single-molecule resolution:

  • Track individual DER1/Derlin-1 molecules during ERAD events

  • Measure stoichiometry and dynamics of complex formation

  • Observe channel formation and substrate translocation in real-time

• Single-cell proteomics:

  • Quantify DER1/Derlin-1 protein levels across cell populations

  • Correlate with cellular phenotypes and stress responses

• CRISPR screens with single-cell readouts:

  • Identify genetic interactions with DER1/Derlin-1 at single-cell resolution

  • Discover cell type-specific dependencies

What is the significance of Der1p topology for understanding mammalian DER1/Derlin-1 function?

The topology of Der1p, with four transmembrane domains and both N- and C-termini protruding into the cytoplasm , provides important insights for mammalian DER1/Derlin-1 research:

• Evolutionary conservation assessment:

  • Compare membrane topology across species from yeast to humans

  • Identify conserved structural features critical for function

• Structural basis for channel formation:

  • Investigate how the four transmembrane domains contribute to homo-tetramer formation and channel structure

  • Determine how the lateral gate within the membrane facilitates substrate access

• Cytoplasmic domain functions:

  • Analyze how N- and C-terminal domains that extend into the cytoplasm contribute to function

  • Identify interaction surfaces for cytosolic ERAD components

• Structure-guided mutagenesis:

  • Design mutations based on topological information

  • Test functional consequences in complementation assays across species

• Homology modeling opportunities:

  • Use yeast Der1p structural information to model mammalian Derlin-1

  • Predict functional domains and critical residues for experimental validation

How does DER1/Derlin-1 coordinate with other Derlin family members in mammals?

Unlike yeast, mammals possess multiple Derlin family members (Derlin-1, Derlin-2, Derlin-3) with potentially overlapping functions:

• Comparative expression analysis:

  • Map tissue-specific and developmental expression patterns of Derlin family members

  • Identify contexts where they are co-expressed versus uniquely expressed

• Substrate specificity determination:

  • Compare the repertoire of ERAD substrates handled by different Derlins

  • Identify sequence or structural features that determine substrate preference

• Compensation mechanisms:

  • Analyze changes in expression of other Derlins upon DER1/Derlin-1 depletion

  • Determine functional redundancy through combinatorial knockout approaches

• Complex formation analysis:

  • Investigate whether Derlins form homo- versus hetero-multimeric complexes

  • Characterize the composition and stoichiometry of different complexes

• Specialized functions:

  • Determine unique roles of DER1/Derlin-1 in processes like viral immune evasion

  • Compare involvement in growth factor receptor regulation

This comprehensive understanding of DER1/Derlin-1 within the broader Derlin family context will provide insights into the evolution and specialization of ERAD machinery in higher organisms.